It achieves antibacterial effect by inhibiting the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hindering bacterial replication. It has good antibacterial effect on most Enterobacteriaceae, some Gram-positive bacteria and Legionella, mycoplasma, Chlamydia, etc., but has poor effect on anaerobic bacteria and enterococci.

No specific description provided

This product belongs to the propionic acid class of nonsteroidal anti-inflammatory drugs, with anti-inflammatory, analgesic and antipyretic effects. It reduces the synthesis of inflammatory mediators prostaglandins by inhibiting cyclooxygenase, so that the swelling and pain of local tissues caused by prostaglandins can be controlled. The anti-inflammatory effect of this product is stronger than that of ibuprofen, and the analgesic effect is better than that of ibuprofen, phenylbutazone and aspirin, while the gastric mucosal damage effect is lower than that of aspirin and phenylbutazone. It causes slight damage to the digestive tract and the drug effect is long-lasting. This drug has a central muscle relaxant effect.

This product belongs to the benzamide antipsychotic drug. Its characteristic action is to selectively block the dopamine (DA2) receptors of the mesolimbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric juice secretion inhibitory effects.